Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
November 30, 2001
Primary Completion Date
February 28, 2009
Conditions
Male Breast CancerRecurrent Breast CancerRecurrent Endometrial CarcinomaRecurrent Gastric CancerRecurrent Non-small Cell Lung CancerRecurrent Ovarian Epithelial CancerRecurrent Small Cell Lung Cancer
Interventions
BIOLOGICAL
trastuzumab
Given IV
DRUG
paclitaxel
Given IV
BIOLOGICAL
recombinant interleukin-12
Given SC
Trial Locations (1)
43210
Ohio State University Medical Center, Columbus
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00028535 - Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter